Marc Frahm
Stock Analyst at TD Cowen
(0.12)
# 3,311
Out of 4,420 analysts
12
Total ratings
16.67%
Success rate
-26.64%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SANA Sana Biotechnology | Initiates: Market Perform | n/a | $10.04 | - | 1 | Aug 14, 2023 | |
| CGEM Cullinan Oncology | Initiates: Outperform | n/a | $29.35 | - | 1 | Jun 15, 2023 | |
| INCY Incyte | Maintains: Outperform | $100 → $93 | $54.37 | +71.05% | 2 | May 3, 2023 | |
| XLO Xilio Therapeutics | Initiates: Outperform | n/a | $1.26 | - | 1 | Nov 16, 2021 | |
| TBPH Theravance Biopharma | Downgrades: Market Perform | n/a | $9.54 | - | 1 | Aug 24, 2021 | |
| NUVL Nuvalent | Initiates: Outperform | n/a | $68.64 | - | 1 | Aug 23, 2021 | |
| ELEV Elevation Oncology | Initiates: Outperform | n/a | $3.48 | - | 1 | Jul 20, 2021 | |
| JANX Janux Therapeutics | Initiates: Outperform | n/a | $61.50 | - | 1 | Jul 6, 2021 | |
| DAWN Day One Biopharmaceuticals | Initiates: Outperform | n/a | $17.08 | - | 1 | Jun 21, 2021 | |
| INZY Inozyme Pharma | Initiates: Outperform | n/a | $4.60 | - | 1 | Aug 18, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Outperform | n/a | $7.20 | - | 1 | Feb 24, 2020 |
Sana Biotechnology
Aug 14, 2023
Initiates: Market Perform
Price Target: n/a
Current: $10.04
Upside: -
Cullinan Oncology
Jun 15, 2023
Initiates: Outperform
Price Target: n/a
Current: $29.35
Upside: -
Incyte
May 3, 2023
Maintains: Outperform
Price Target: $100 → $93
Current: $54.37
Upside: +71.05%
Xilio Therapeutics
Nov 16, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.26
Upside: -
Theravance Biopharma
Aug 24, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $9.54
Upside: -
Nuvalent
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $68.64
Upside: -
Elevation Oncology
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.48
Upside: -
Janux Therapeutics
Jul 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $61.50
Upside: -
Day One Biopharmaceuticals
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $17.08
Upside: -
Inozyme Pharma
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $4.60
Upside: -
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Outperform
Price Target: n/a
Current: $7.20
Upside: -